We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Drug Products » The 21st Century Cures Act — Impact on Pharmaceuticals - Webinar CD/Transcript

Other Options

Audio CD/Transcript - Feb. 15, 2017

$287.00

Audio CD/Transcript - Feb. 15, 2017

$258.00

Audio CD/Transcript - Feb. 15, 2017

$244.00

Audio CD/Transcript - Feb. 15, 2017

$230.00

Audio CD/Transcript - Feb. 15, 2017

$215.00

The 21st Century Cures Act — Impact on Pharmaceuticals - Webinar CD/Transcript

$287.00
Drug Products

Product Details

The 21st Century Cures Act — Impact on Pharmaceuticals: What You Need to Know to Thrive in 2017

What do you need to know about the 21st Century Cures Act in order to thrive this year?

The passage of the 21st Century Cures Act aims to boost research and ease drug approvals. It will have you scrambling to meet new mandates… regulations and guidance in several key areas — including data development and maintenance, technical support, clinical approvals and pre-approval submissions, development agreements, inspections and reviews, supplemental NDAs, IRBs…and much, much more.

So why not join legal expert Jim O’Reilly for a discussion on the biggest change in the daily activities of the drug regulatory community in five decades.

After attending this incisive 90-minute session, you’ll understand:

  • How Congress has thrown a curve at the FDA’s often stringent review process, enabling far broader acceptance of submitted experience data
  • How to add new "real world evidence" and "data summaries" into submissions
  • How to benefit from Congress' locking FDA into development agreements
  • How to avoid supplemental NDAs on new indications by pitching to insurers for their provider formularies without FDA control
  • How to utilize patient input and patient experiences in pre-approval submissions
  • How to accelerate approval of your new uses for drugs and still stay in compliance with current FDA regulation and guidance
  • How to develop cutting-edge strategies to maximize the numerous opportunities for more rapid drug development under the Cures Act and not fall behind your competition
  • How to accelerate with review vouchers and orphan drug grants
  • How the elimination of local IRB approvals will accelerate approvals to the FDA

Order today and learn what has changed with the 21st Century Cures Act and what you need to watch for in your submissions to the FDA.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing